Literature DB >> 27904939

[Time interval between neoadjuvant radiochemotherapy and surgery in rectal cancer : No impact on the pathologic complete response rate?]

Cihan Gani1, Daniel Zips2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27904939     DOI： 10.1007/s00066-016-1080-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6).

Authors:  Jérémie H Lefevre; Laurent Mineur; Salma Kotti; Eric Rullier; Philippe Rouanet; Cécile de Chaisemartin; Bernard Meunier; Jafari Mehrdad; Eddy Cotte; Jérome Desrame; Mehdi Karoui; Stéphane Benoist; Sylvain Kirzin; Anne Berger; Yves Panis; Guillaume Piessen; Alain Saudemont; Michel Prudhomme; Frédérique Peschaud; Anne Dubois; Jérome Loriau; Jean-Jacques Tuech; Guillaume Meurette; Renato Lupinacci; Nicolas Goasgen; Yann Parc; Tabassome Simon; Emmanuel Tiret
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

2.  Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.

Authors:  Yoo-Kang Kwak; Kyubo Kim; Jong Hoon Lee; Sung Hwan Kim; Hyeon Min Cho; Dae Yong Kim; Tae Hyun Kim; Sun Young Kim; Ji Yeon Baek; Jae Hwan Oh; Taek Keun Nam; Mee Sun Yoon; Jae Uk Jeong; Eui Kyu Chie; Hong Seok Jang; Jae Sung Kim
Journal:  Radiother Oncol       Date:  2016-04-19       Impact factor: 6.280

3.  Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Authors:  Julio Garcia-Aguilar; Oliver S Chow; David D Smith; Jorge E Marcet; Peter A Cataldo; Madhulika G Varma; Anjali S Kumar; Samuel Oommen; Theodore Coutsoftides; Steven R Hunt; Michael J Stamos; Charles A Ternent; Daniel O Herzig; Alessandro Fichera; Blase N Polite; David W Dietz; Sujata Patil; Karin Avila
Journal:  Lancet Oncol       Date:  2015-07-14       Impact factor: 41.316

4.  Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Authors:  Claus Rödel; Ullrich Graeven; Rainer Fietkau; Werner Hohenberger; Torsten Hothorn; Dirk Arnold; Ralf-Dieter Hofheinz; Michael Ghadimi; Hendrik A Wolff; Marga Lang-Welzenbach; Hans-Rudolf Raab; Christian Wittekind; Philipp Ströbel; Ludger Staib; Martin Wilhelm; Gerhard G Grabenbauer; Hans Hoffmanns; Fritz Lindemann; Anke Schlenska-Lange; Gunnar Folprecht; Rolf Sauer; Torsten Liersch
Journal:  Lancet Oncol       Date:  2015-07-15       Impact factor: 41.316

5.  Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.

Authors:  Iris D Nagtegaal; Cornelis J H van de Velde; Erik van der Worp; Ellen Kapiteijn; Phil Quirke; J Han J M van Krieken
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

6.  Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.

Authors:  D A M Sloothaak; D E Geijsen; N J van Leersum; C J A Punt; C J Buskens; W A Bemelman; P J Tanis
Journal:  Br J Surg       Date:  2013-03-27       Impact factor: 6.939

7.  Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone.

Authors:  Christopher Schroeder; Cihan Gani; Ulf Lamprecht; Claus Hann von Weyhern; Martin Weinmann; Michael Bamberg; Bernhard Berger
Journal:  Int J Hyperthermia       Date:  2012-09-24       Impact factor: 3.914

8.  RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.

Authors:  J P Maarten Burbach; Helena M Verkooijen; Martijn Intven; Jean-Paul J E Kleijnen; Mirjam E Bosman; Bas W Raaymakers; Wilhelmina M U van Grevenstein; Miriam Koopman; Enrica Seravalli; Bram van Asselen; Onne Reerink
Journal:  Trials       Date:  2015-02-22       Impact factor: 2.279
  8 in total
  2 in total

1.  The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Authors:  Tarkan Jäger; Daniel Neureiter; Mohammad Fallaha; Philipp Schredl; Tobias Kiesslich; Romana Urbas; Eckhard Klieser; Josef Holzinger; Felix Sedlmayer; Klaus Emmanuel; Adam Dinnewitzer
Journal:  Strahlenther Onkol       Date:  2018-08-01       Impact factor: 3.621

2.  Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation.

Authors:  Dorian Gottwald; Florian Putz; Nora Hohmann; Maike Büttner-Herold; Markus Hecht; Rainer Fietkau; Luitpold Distel
Journal:  BMC Mol Cell Biol       Date:  2020-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.